A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial)
Titel:
A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial)
Auteur:
Mead, Graham M. Barrans, Sharon L. Qian, Wendi Walewski, Jan Radford, John A. Wolf, Max Clawson, Simon M. Stenning, Sally P. Yule, Claire L. Jack, Andrew S.